U.K. Drug Regulator Follows U.S. FDA; Seeks Closer Ties With India's DCGI
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Following U.S. FDA's moves to work closely with the Drug Controller General of India - the Indian drug regulator - the United Kingdom's Medicines and Healthcare products Regulatory Agency has held discussions with the Indian health department officials to build closer relationships
You may also be interested in...
U.S. FDA Mulls Joint Action With India’s DCGI For Closer Scrutiny Of Clinical Research Organizations
MUMBAI - After setting up a full-fledged India office, U.S. FDA is now planning to initiate its Bioresearch Monitoring Program aimed at comprehensive on-site inspections and data audits designed to monitor all aspects of U.S. FDA-regulated research
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).